Impact BioMedical Inc. IBO
4.02 USD +0.01 (+0.25%)
At closeNov 3, 2026, 4:00 PM EST
4.02 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
4.00 Day range 4.33
2.43 52-week range 10.51
- YTD
- -37.09%
- 1 year
- -40.44%
Financial health
Altman Z-Score
2.73 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -1.3×
FY 2020 5y median -4.4× FY 2025
P/S 498×
FY 2020 5y median 498× FY 2025
P/B 1.3×
FY 2020 5y median 1.3× FY 2025
P/FCF -8.4×
FY 2020 5y median -12.2× FY 2025
EV/EBITDA -1.3×
FY 2020 5y median -6.5× FY 2025
EV/Sales 498×
FY 2020 5y median 498× FY 2025
FCF Yield -11.9%
FY 2020 5y median -8.2% FY 2025
Profitability
Gross Margin -1225.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin -13343.8%
FY 2020 5y median -6808.0% FY 2025
Net Margin -36993.8%
FY 2020 5y median -14102.0% FY 2025
ROE -93.9%
FY 2020 5y median -23.9% FY 2025
ROIC -21.6%
FY 2020 5y median -9.2% FY 2025
ROA -68.0%
FY 2020 5y median -15.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 85.1%
FY 2020 FY 2025
EPS (diluted) -5407.2%
FY 2020 FY 2025
Free Cash Flow 66.5%
FY 2020 FY 2025
Financial Health
Current Ratio 0.4×
FY 2020 5y median 0.0× FY 2025
Quick Ratio 0.3×
FY 2020 5y median 0.0× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.3× FY 2025
Net Debt / EBITDA 0.0×
FY 2020 5y median -1.6× FY 2025
Interest Coverage -5.4×
FY 2020 5y median -9.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31